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AbstrACt
Objective Dietary factors and physical activity may alter 
prostate cancer progression. We explored the feasibility of 
lifestyle interventions following radical prostatectomy for 
localised prostate cancer.
Design Patients were recruited into a presurgical 
observational cohort; following radical prostatectomy, 
they were offered randomisation into a 2×3 factorial 
randomised controlled trial (RCT).
setting A single National Health Service trust in the South 
West of England, UK.
Participants Those with localised prostate cancer and 
listed for radical prostatectomy were invited to participate.
randomisation Random allocation was performed by 
the Bristol Randomised Trial Collaboration via an online 
system.
Interventions Men were randomised into both a modified 
nutrition group (either increased vegetable and fruit, and 
reduced dairy milk; or lycopene supplementation; or 
control) and a physical activity group (brisk walking or 
control) for 6 months.
blinding Only the trial statistician was blind to allocations.
Primary outcome measures Primary outcomes 
were measures of feasibility: randomisation rates and 
intervention adherence at 6 months. Collected at trial 
baseline, three and six months, with daily adherence 
reported throughout. Our intended adherence rate was 
75% or above, the threshold for acceptable adherence was 
90%.
results 108 men entered the presurgical cohort, and 81 
were randomised into the postsurgical RCT (randomisation 
rate: 93.1%) and 75 completed the trial. Of 25 men in the 
nutrition intervention, 10 (40.0%; 95% CI 23.4% to 59.3%) 
adhered to the fruit and vegetable recommendations 
and 18 (72.0%; 95% CI 52.4% to 85.7%) to reduced 
dairy intake. Adherence to lycopene (n=28), was 78.6% 
(95% CI 60.5% to 89.8%), while 21/39 adhered to the 
walking intervention (53.8%; 95% CI 38.6% to 68.4%). 
Most men were followed up at 6 months (75/81; 92.6%). 
Three ‘possibly related’ adverse events were indigestion, 
abdominal bloating and knee pain.
Conclusions Interventions were deemed feasible, with 
high randomisation rates and generally good adherence. A 
definitive RCT is proposed.
trial registration number ISRCTN 99048944.
IntrODuCtIOn
Prostate cancer is the most common male 
cancer in the UK. There were 47 740 new 
cases diagnosed in 2016,1 accounting for 26% 
of UK male cancers. Furthermore, in 2016, 
there were 11 600 prostate cancer deaths, 
making the disease the second most common 
cause of UK cancer- related death.1 Following 
improvements in clinical diagnosis and treat-
ment leading to rising survival rates, more 
men are living longer with the disease, and 
there is growing interest in developing life-
style modifications for tertiary prevention of 
prostate cancer morbidity and mortality.2
Evidence summarised by the World Cancer 
Research Fund3 suggests that vegetables 
and fruit, and associated micronutrients 
(eg, carotenoids, some vitamins and flavo-
noids), may reduce prostate cancer risk, 
while calcium and dairy intake may increase 
strengths and limitations of this study
 ► Robust, gold standard, randomised control trial 2×3 
factorial design, with 6 month follow- up.
 ► Excellent retention rates, with only six participants 
withdrawing or being lost to follow- up.
 ► Outcomes included objective biochemical measures 
that are not open to responder bias.
 ► Except for the statistician, all researchers and par-
ticipants were unblinded; blinding was not feasible 
given the nature of the intervention.
Protected by copyright.
 o
n
 N
ovem
ber 28, 2019 at University of Bristol Library.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-029480 on 6 November 2019. Downloaded from 
2 Hackshaw- McGeagh LE, et al. BMJ Open 2019;9:e029480. doi:10.1136/bmjopen-2019-029480
Open access 
risk. Our recent review of 44 randomised controlled 
trials (RCTs) of dietary, nutrition and physical activity 
interventions suggest various dietary interventions (eg, 
low fat diet, soya and soya foods, selenium, lycopene 
or green tea) may reduce prostate cancer progression 
and mortality.2 However, many studies were assessed as 
being of low quality (with high or unclear risk of bias), 
underpowered, inadequately reported, of short dura-
tion or measuring surrogate outcomes, such as prostate- 
specific antigen doubling time, which has an uncertain 
relationship with prostate cancer progression. We there-
fore wanted to conduct a high- quality, low risk of bias, 
adequately powered, well reported, 6- month trial to 
explore the feasibility of a simple, easy to implement ‘real 
life’, dietary and physical activity intervention.
Lycopene, an antioxidant phytonutrient, has been 
observed to reduce prostate cancer progression,4 5 while 
high- fat milk intake has been positively associated with 
prostate cancer progression.6 However, robust RCT 
evidence for the effects of lycopene or milk intake in rela-
tion to prostate cancer progression is lacking.3
Moderate to vigorous physical activity is another poten-
tially promising intervention7; research suggests that 
it is safe and can benefit quality of life throughout the 
cancer journey,8 but the evidence is also largely based on 
observational data: further RCTs are needed for defini-
tive evidence. Moderate to vigorous intensity activity is 
defined as activities that cause sweating and increased 
heart and respiratory rate, of which brisk walking is an 
example.9 Brisk walking has been associated with anti-
cancer cellular behaviour10 and does not require special-
ised equipment or training.
Some men spontaneously and positively alter lifestyle 
behaviours on receiving a diagnosis of prostate cancer. 
However, for many men, this is not the case,11–13 and 
additional interventions are necessary to promote and 
maintain behavioural change.14–16 Radical prostatectomy 
(surgical removal of the prostate) is a common treat-
ment for localised disease.1 We established a 2×3 facto-
rial RCT—the Prostate Cancer: Evidence of Exercise and 
Nutrition Trial (PrEvENT)—to explore the feasibility of 
introducing modified nutrition (increased vegetables 
and fruit combined with reduced dairy milk) or lycopene 
supplements and physical activity (brisk walking) inter-
ventions in men treated with radical prostatectomy for 
localised prostate cancer. Here we report the primary trial 
findings.
MAterIAls AnD MethODs
trial design and participants
The trial protocol has been published elsewhere.17 In 
brief, men from a single National Health Service trust in 
the South West of England, UK, who were diagnosed with 
localised prostate cancer and listed for radical prostatec-
tomy, were invited to participate in PrEvENT between 
August 2014 and May 2016. There were two phases: (1) 
recruitment of men scheduled for radical prostatectomy 
into a baseline cohort for epidemiological character-
isation (ie, presurgical questionnaire data and blood 
sampling) of the target population; and (2) recruitment 
of the men once they had their radical prostatectomy into 
a 2×3 factorial RCT.
Cohort and RCT inclusion criteria were: localised pros-
tate cancer; undergoing radical prostatectomy; capacity 
to provide informed consent; aged 18 years or over; and 
sufficient understanding of the English language. Exclu-
sion criteria were: inability to give informed consent; 
unavailability for follow- up; identified as unsuitable to 
participate by the treating clinician; comorbidities (this 
could include uncontrolled congestive heart failure or 
angina, recent myocardial infarction or breathing diffi-
culties requiring oxygen use or hospitalisation), allergies 
or religious beliefs that could prevent participation in the 
intervention (RCT only); and regularly taking lycopene 
supplements or routinely exercising vigorously (RCT 
only).
Men were approached to participate in the cohort by 
their clinical care team or a research nurse. Nurse- led 
consent at cohort recruitment included optional approval 
for prostate tissue extracted during surgery to be used for 
research purposes and willingness to be contacted about 
future involvement in further research. Approximately 
6 weeks after surgery, the men who were participating 
in the cohort were invited to participate in the RCT. 
Six weeks postsurgery was identified as the ideal time to 
approach men to participate in the trial, as this is the time 
point where men are generally informed by their clinical 
team that they should be able to begin exercising again 
after radical prostatectomy.
randomisation
Random allocation was performed by the Bristol 
Randomised Trial Collaboration via an online system to 
ensure that the recruiting nurses could not uncover allo-
cation of trial group in advance (concealment of alloca-
tion). The research nurse, research team and men were 
not blind to intervention allocation, because this would 
have been unfeasible given the nature of the interven-
tions, while the trial statistician was blind to allocations. 
Men were randomised at the trial baseline appointment, 
where they were provided with all information related to 
their intervention group in person by the research nurse.
Interventions
Men were randomised to both a physical activity interven-
tion (two levels; brisk walking vs control) and a nutrition 
intervention (three levels; modified nutrition group vs 
lycopene vs control). Men in the physical activity inter-
vention group were instructed to walk at a brisk pace 
for 30 min on at least 5 days a week in addition to their 
usual physical activity, while control group men were 
asked to continue with their usual physical activity. Men 
in the plant- based diet group (modified nutrition) were 
instructed to eat as many portions of fruit and vegetables 
as possible a day, aiming for at least five daily portions 
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(printed instructions explained how to measure a 
portion). In addition, men in the plant- based diet group 
were asked to reduce their dairy milk intake as much as 
possible and to use a non- dairy alternative, for example, 
soy, almond or rice milk as often as possible. Men in the 
lycopene group were asked to consume one 10 mg lyco-
pene capsule daily (Holland and Barrett, a UK supplier 
of nutritional supplements, supplied to the men and 
paid for by the trial). Men in the nutrition control group 
were asked to continue with their usual diet. Control men 
who asked for physical activity or nutrition advice were 
provided with publicly available information. Instructions 
on how to perform the interventions were administered 
by the research nurse. All men were asked to follow their 
allocated interventions for 6 months and were contacted 
at 1, 2, 5, 8, 13, 15 and 18 weeks postrandomisation. The 
method of contact was chosen by the man: text message, 
emails, phone call or post. The content of the commu-
nication was structured and consistent, regardless of the 
method of delivery, to ensure similar contact and infor-
mation provision across participants. These communica-
tions contained recipe ideas (plant- based diet group) and 
theory developed motivational messages to encourage 
continuation of the trial group intervention.17
Data collection
Men attended the hospital for a research nurse appoint-
ment at trial baseline (randomisation), 3 and 6 months 
and completed patient- reported outcome measures 
(PROMs) (paper questionnaires). If the man was unable 
to attend the hospital, the questionnaire was sent in the 
post. Questionnaires analysed here to illustrate the impact 
of adherence were the Recent Physical Activity Ques-
tionnaire (RPAQ)18 and Food Frequency Questionnaire 
(FFQ),19 while the other PROMs are detailed elsewhere.17 
At baseline, men reported sociodemographic informa-
tion (level of education, marital status, occupation and 
ethnicity) and family medical history of cancer. At base-
line, 3 and 6 months, smoking and alcohol use, and nurse- 
measured anthropometry, were recorded. Non- fasting 
blood samples were collected at baseline and 6 months. 
All men completed a paper daily monitoring form for 
the 6- month duration logging daily step count; addition-
ally, the physical activity intervention group recorded the 
duration of brisk walking in minutes; the plant- based diet 
nutrition group recorded the daily number of portions 
of fruit or vegetables consumed and the amount of dairy 
milk replaced by non- dairy alternatives (all/some/none), 
while the lycopene supplementation group recorded 
whether they had taken the lycopene supplement (yes/
no).
Public and patient involvement (PPI)
A prostate cancer PPI group was involved from the early 
protocol development stages. The PPI group contributed 
to discussions regarding intervention content and length, 
reviewed trial documentations, such as consent forms 
and participant information sheets, revised intervention 
instructions to improve readability and completed ques-
tionnaires to assess participant burden.
sample size calculation
The sample size calculation, described previously,17 iden-
tified a required minimum sample size of 75 men to 
estimate an adherence rate (the primary outcome, see 
Primary Outcomes) of 75% with a CI of ±5% (90% power, 
p=0.05) in each group. We aimed to recruit at least 100 
men to the cohort study, anticipating an 80% randomis-
ation rate.
statistical analysis
Analyses included all participants with measurements for 
the primary outcomes and trial baseline values at rando-
misation in an intention to treat analysis. All statistical 
analyses used Stata V.14.20
Primary outcomes
The primary outcomes were: (1) the randomisation 
rate (the number of men agreeing to be randomised 
into the RCT divided by the total number of men in the 
cohort) our intended rate was 80% and (2) adherence 
to the man’s allocated intervention at 6 months following 
randomisation. Our intended adherence rate was 75% 
or above. Adherence was based on the 4 weeks prior to 
the participants’ latest entry in their daily monitoring 
form. Specifically, for each intervention, to assess adher-
ence to the plant- based diet, we analysed the propor-
tion of days that the men reported they consumed five 
or more portions of fruit or vegetables and the propor-
tion of days they replaced all or some of their dairy milk 
with non- dairy alternative. Adherence to the lycopene 
intervention was based on the proportion of days that 
the men reported they took the lycopene supplement. 
The threshold for acceptable adherence was 90%, which 
equates to adhering to the fruit and vegetable or lycopene 
interventions on 26 out of a possible 28 days. Adherence 
to the physical activity intervention was based on number 
of days of doing 30 or more minutes of self- reported brisk 
walking. Across the 28 days over which adherence was 
monitored, men were considered to have adhered 100% 
to the physical activity intervention if they did 30+ min 
of walking on at least 20 days, while 90% adherence was 
defined as doing 30+ min of walking on 18 of the 28 days.
Secondary outcomes
PrEvENT secondary outcomes were trial retention, blood 
biomarkers of fruit and vegetable consumption, self- 
reported food consumption (measured using the FFQ), 
self- reported physical activity (measured using the RPAQ) 
and trial tolerability (measured by qualitative interviews 
and adverse events); these outcomes are reported here. 
Other secondary outcomes were change in prostate 
specific antigen and insulin- like growth factor, change in 
urinary symptoms, psychological factors, health beliefs, 
quality of life, fatigue, general health, accelerometer 
and pedometer data and lifestyle behaviours (smoking 
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and drinking). These latter secondary outcomes are not 
reported here.
As secondary measures of adherence in the dietary 
interventions, serum concentrations of lutein, zeaxanthin, 
β-cryptoxanthin, α-carotene, β-carotene and lycopene were 
measured by reverse- phase high- performance liquid chro-
matography.21 Assays were standardised against appropriate 
National Institute of Standards and Technology reference 
materials.22 These assays are also externally quality assured 
by participation in the French Society for Vitamins and 
Biofactors quality assurance scheme.23
Mean portions of fruit and vegetables consumed per 
day were calculated from the FFQ. Physical activity energy 
expenditure was derived from the RPAQ. The effects of 
the nutrition and physical activity interventions on fruit 
and vegetable consumption and energy expenditure, 
respectively, were assessed using multivariable linear 
regression. As prespecified, we assumed no interac-
tion between the interventions and tested this through 
repeating the multivariable linear regression analyses 
with an interaction term between the interventions and 
application of the Wald test with the null hypothesis that 
the interaction terms were zero. We also compared the 
consumption of non- dairy milk recorded in the FFQ 
(categorised into ‘Dairy’: full cream, semi skimmed, 
skimmed or dried milk; and ‘Non- dairy’: soya and other) 
and blood biomarkers of fruit and vegetable consump-
tion (lutein, zeaxanthin, beta cryptoxanthin, alpha caro-
tene, beta carotene and lycopene) between trial groups 
using χ2 tests for categorical outcomes and Kruskal- Wallis 
tests for continuous outcomes, respectively. A Bonferroni 
correction was applied to p values (multiplied by two) 
for post hoc pairwise comparisons between the nutrition 
groups (no comparison was made between the lycopene 
and plant- based interventions) calculated using pairwise 
χ2 tests for categorical outcomes and Wilcoxon rank- sum 
tests for continuous outcomes. Intervention tolerability 
was assessed via adverse events and post- trial qualitative 
interviews (reported elsewhere).
Exploratory outcomes
To describe change in adherence from the beginning to 
the end of the trial period, adherence was also calculated 
for the first 4 weeks of daily data monitoring forms after the 
participants earliest entry. We also calculated weekly adher-
ence to the interventions from 1 to 26 weeks and overlaid 
the postrandomisation contact reminders.
results
study recruitment, participant characteristics, randomisation 
and follow-up
Between August 2014 and May 2016, 292 eligible men 
scheduled for radical prostatectomy were invited to partic-
ipate and of these, 108 (37.0 %) entered the cohort study 
(figure 1). The most common reasons for not enrolling 
were: distance to travel (n=75), not being contactable 
(n=58) or uninterested in taking part (n=28). Of the 
108 men, 96 completed cohort follow- up, a further nine 
were no longer eligible for the RCT, thus 87 were invited 
into the RCT and 81 (93.1%, 95% CI 85.8% to 96.8%) 
consented to be randomised, a trial primary endpoint.
Men were randomised on average around 8 weeks after 
surgery (range: 4 weeks (31 days) to 15 weeks (108 days)). 
The men were on average 64.0 years of age (SD=6.3 years), 
with 88% (n=68) self- reporting as white British and with a 
median preoperative prostate specific antigen of 8.7 ng/
mL (IQR: 5.9–12.3). Almost all men were former or never 
smokers (97.4%, n=75), and 20% (n=16) self- reported as 
consuming more than 14 units of alcohol per week. In 
general, baseline characteristics were similarly distributed 
between trial groups (table 1). Seventy- five of the 81 men 
completed the trial (92.6 %); three were lost to follow- up 
and three withdrew. Those who withdrew were for reasons 
unrelated to the interventions. We present the results of 
the 75 men who completed the trial.
Primary outcomes
Adherence to interventions by self-reported daily records
Adherence for at least 90% of the time was 40.0% (95% CI 
23.4% to 59.3%, n=10 of 25) in the plant- based diet group 
for the fruit and vegetable component and 72.0% (95% 
CI 52.4% to 85.7%, n=18 of 25) for the dairy milk compo-
nent. In the lycopene group, 78.6% (95% CI 60.5% to 
89.8%, n=22 of 28) of men adhered at least 90% of the 
time. Adherence to the physical activity intervention was 
53.8% (95% CI 38.6% to 68.4%, n=21 of 39) at least 90% 
of the time (table 2). Weekly adherence to the interven-
tions appeared stable for most of the intervention period, 
with a potential drop- off after week 22 in the lycopene 
and plant based diet arms of the nutrition interventions 
(figure 2). Postrandomisation reminders (weeks 1, 2, 5, 
8, 13 and 18) did not appear to lead to changes in adher-
ence to the interventions.
secondary outcomes
effects of the interventions on self-reported diet and physical 
activity PrOMs
Those men in the plant- based diet intervention group 
reported consuming a mean of 9.9 portions (SD=4.7 
portions) of fruit and vegetables a day based on the FFQ 
PROMs. This was almost four portions (adjusted differ-
ence=3.7, 95% CI 1.1 to 6.4 portions/day) more than 
those in the control group (mean=6.2, SD=3.8 portions) 
(p=0.007). Those in the lycopene intervention groups 
reported consuming a mean of 8.2 portions per day 
(SD=4.8 portions), which was 2.1 portions (95% CI −0.5 
to 4.7) more per day than the control group (p=0.12) 
(table 3). Consumption of non- dairy milk was highest in 
the plant- based diet intervention group (78.3%, 95% CI 
58.1% to 90.3%, n=18 of 23) and was very low otherwise 
(7.7%, 95% CI 2.1% to 24.1%, 2 of 26; and 0%, 95% CI 
0.0% to 16.1%, 0 of 20 for the lycopene intervention and 
control groups, respectively, p<0.001) (table 3).
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Figure 1 CONSORT diagram. CONSORT, Consolidated Standards of Reporting Trials; FU, follow- up; PA, physical activity; 
RCT, randomised controlled trial.
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Table 1 Participant characteristics, baseline measures and clinical data by intervention groups
n (% of participants in group)
Nutrition (n=81) Physical activity (PA) (n=81)
Lycopene intervention 
(n=28, 34.6%)
Plant- based diet 
intervention (n=27, 33.3%)
Nutrition control
(n=26, 32.1%)
PA control (n=39, 
48.1%)
PA intervention 
(n=42, 51.9%)
Participant characteristics
Age (years)* 62.9 (7.7) 64.6 (5.7) 64.7 (5.5) 62.5 (6.9) 65.5 (5.5)
Ethnicity
  White British 23 (88.5) 23 (85.2) 22 (91.7) 33 (86.8) 35 (89.7)
Highest education level†
  Standard or less (eg, o- levels 
and GCSE)
7 (26.9) 12 (44.4) 14 (60.9) 20 (52.6) 13 (34.2)
  Further education (eg, A- 
levels, HND and university 
degree)
19 (73.1) 15 (55.6) 9 (39.1) 18 (47.4) 25 (65.8)
Marital status
  Married/in a relationship 23 (88.5) 22 (81.5) 22 (95.7) 33 (86.8) 34 (89.5)
Father had prostate cancer
  Yes 11 (44.0) 2 (7.4) 1 (4.3) 8 (21.6) 6 (15.8)
Smoking status
  Current 0 (0.0) 0 (0.0) 2 (7.7) 1 (2.7) 1 (2.5)
  Former 9 (37.5) 13 (48.1) 16 (61.5) 21 (56.8) 17 (42.5)
  Never 15 (62.5) 14 (51.9) 8 (30.8) 15 (40.5) 22 (55.0)
Alcohol consumption (units/
week)‡
1.0 (0.0; 7.0) 4.0 (0.0; 12.0) 4.5 (0.0; 22.0) 2.0 (0.0; 7.0) 4.0 (0.0; 13.0)
Alcohol consumption (categorised)§
  Non- drinker (0 units/week) 14 (50.0) 9 (33.3) 8 (30.8) 17 (43.6) 14 (33.3)
  ≤14 units/week 11 (39.3) 14 (51.9) 9 (34.6) 15 (38.5) 19 (45.2)
  >14 units/week 3 (10.7) 4 (14.8) 9 (34.6) 7 (17.9) 9 (21.4)
Body mass index (kg/m2)* 26.2 (3.6) 26.7 (3.6) 26.8 (3.1) 26.6 (3.5) 26.6 (3.3)
Baseline measures and clinical data
Presurgical prostate specific 
antigen (ng/mL)‡
7.8 (5.2; 11.0) 8.4 (5.7; 9.6) 10.6 (8.4; 15.0) 8.4 (5.7; 11.0) 8.9 (6.4; 12.7)
Baseline fruit and vegetable 
consumption (portions/day)*
7.5 (4.7) 8.5 (5.7) 7.3 (2.4)   8.2 (5.2)   7.4 (3.7)
Baseline energy expenditure (kJ/
kg/day)*
27.2 (32.9) 22.8 (13.9) 27.4 (21.6) 23.1 (23.0) 28.3 (25.0)
Type of milk consumed most often
  Dairy 22 (88.0) 22 (84.6) 24 (96.0) 30 (83.3) 38 (95.0)
  Non- dairy 3 (12.0) 4 (15.4) 1 (4.0) 6 (16.7) 2 (5.0)
Lutein – µmol/L‡ 0.36 (0.28; 0.55) 0.40 (0.32; 0.52) 0.35 (0.20; 0.46) 0.35 (0.28; 0.52) 0.38 (0.28; 0.51)
Zeaxanthin – µmol/L‡ 0.11 (0.09; 0.16) 0.10 (0.09; 0.12) 0.10 (0.06; 0.13) 0.11 (0.08; 0.12) 0.10 (0.08; 0.14)
Beta cryptoxanthin – µmol/L‡ 0.22 (0.16; 0.36) 0.25 (0.15; 0.36) 0.19 (0.11; 0.39) 0.22 (0.14; 0.32) 0.24 (0.14; 0.40)
Alpha carotene – µmol/L‡ 0.07 (0.05; 0.09) 0.08 (0.06; 0.10) 0.07 (0.05; 0.08) 0.07 (0.05; 0.08) 0.07 (0.06; 0.09)
Beta carotene – µmol/L‡ 0.64 (0.46; 1.06) 0.72 (0.50; 1.16) 0.56 (0.47; 0.84) 0.66 (0.47; 0.89) 0.64 (0.48; 1.07)
Lycopene – µmol/L‡ 1.35 (1.03; 1.69) 1.24 (0.92; 1.44) 1.20 (0.90; 1.59) 1.23 (0.92; 1.47) 1.29 (1.04; 1.62)
*Values are mean (SD).
†O- level, GCSE: national school examinations at age 16 years. A- level: national school examinations at age 18 years. Higher national diploma (HND) is a work- 
related course provided by higher and further education colleges in the UK. A full- time HND takes 2 years to complete and generally is the equivalent to 2 years at 
university.
‡Values are median (25%; 75%).
§Non- drinker: 0 units/week; moderate: >0 and ≤14 units/week; hazardous: >14 and ≤50 units/week; harmful: >50 units/week.
Those men in the physical activity intervention and 
control groups reported very similar mean energy expen-
diture based on the PROMs data (mean=39.7 kJ/kg/day, 
SD=26.3 kJ/kg/day, and mean=40.8 kJ/kg/day, SD=28.6 kJ/
kg/day, respectively) (adjusted difference=−0.8 kJ/kg/day, 
95% CI −13.6 to 11.9 kJ/kg/day, p=0.90) (table 3).
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Table 2 Adherence to the interventions by self- reported daily monitoring*
Adherence 
to lycopene 
intervention*
Adherence to plant- based diet intervention* Adherence to 
physical activity 
intervention*Fruit and vegetables Dairy replacement
Physical activity (PA)
  PA control (n=36) 30.6% (n=11) 13.9% (n=5) 30.6% (n=11) –
  PA intervention (n=39) 28.2% (n=11) 12.8% (n=5) 18.0% (n=7) 53.8% (n=21)
Nutrition
  Lycopene intervention 
(n=28)
78.6% (n=22) – – 28.6% (n=8)
  Plant- based diet 
intervention (n=25)
– 40.0% (n=10) 72.0% (n=18) 28.0% (n=7)
  Nutrition control (n=22) – – – 27.3% (n=6)
*Adherence was based on the 4 weeks prior to the participants’ latest entry in their daily monitoring form. The threshold for acceptable 
adherence was 90%, which equates to adhering to the fruit and vegetable or lycopene interventions on 26 out of a possible 28 days. 
Adherence to the PA intervention equates to doing 30+ min of walking on 18 of the 28 days.
Figure 2 Weekly adherence to the intervention from 0 to 26 weeks for participants randomised to the lycopene (A) or plant- 
based diet (B) arms of the nutrition intervention and physical activity intervention arm (C).Dashed vertical lines represent 
timepoints (weeks 1, 2, 8, 13, 15 and 18) at which reminders were sent to participants.
There was no evidence of an interaction between the 
nutrition and physical activity interventions (F=0.65, 
p=0.63) so the data are not shown here.
effects of the nutrition intervention on blood biomarkers of 
fruit and vegetable consumption
Lutein (p=0.07), beta cryptoxanthin (p=0.07), beta caro-
tene (p=0.09) and lycopene (p=0.07) were higher in the 
plant- based intervention group than the control group. 
There was no difference in lycopene between the lyco-
pene intervention group compared with the control 
group (p=0.64). No other differences were found between 
the blood biomarkers (table 4).
Intervention tolerability
Nine adverse events, self- reported by participants, were 
classed as unrelated to the interventions and included 
fever, alcohol withdrawal symptoms, urinary symptoms, 
diverticulitis, pneumonia, Campylobacter infection and 
hernia repair procedure. Three adverse events were 
considered as ‘possibly related to the interventions’; 
these were indigestion, abdominal bloating and knee 
pain. Data from qualitative interviews reported else-
where also suggested that men found all the interven-
tions to be acceptable, easy to accommodate and well 
tolerated.24
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Table 3 Effects of interventions on fruit and vegetable consumption, non- dairy milk consumption and energy expenditure at 
6 months
Nutrition (n=75) Physical activity (n=75)
Lycopene 
intervention (n=28)
Plant- based diet 
intervention (n=25)
Nutrition control 
(n=22)
Physical activity 
control (n=36)
Physical activity 
intervention (n=39)
Fruit and vegetable 
(portions/day), 
mean (SD)
8.2 (4.8) 9.9 (4.7) 6.2 (3.8) 8.3 (4.9) 8.1 (4.5)
Adjusted 
difference in fruit 
and vegetable 
consumption 
(portions/day) 
compared with 
the control group* 
(95% CI)
2.07 (-0.51 to 4.65) 3.73 (1.07 to 6.38) – – −0.20 (–2.37 to 1.98)
  P value 0.12† 0.007† 0.86†
Energy expenditure 
(kJ/kg/day), mean 
(SD)
41.8 (23.7) 43.1 (32.0) 34.9 (26.1) 40.8 (28.6) 39.7 (26.3)
Adjusted difference 
in energy 
expenditure (kJ/kg/
day) compared with 
the control group* 
(95% CI)
6.91 (–8.77 to 22.6) 8.19 (–7.89 to 24.3) – – −0.84 (–13.6 to 11.9)
  P value 0.38† 0.31† 0.90†
Type of milk 
consumed most 
often
  Dairy, n (%) 24 (92.3) 5 (21.7) 20 (100.0) 22 (66.7) 27 (75.0)
  Non- dairy, n (%) 2 (7.7) 18 (78.3) 0 (0.0) 11 (33.3) 9 (25.0)
  P values 0.41‡ <0.001‡ <0.001§ 0.08§
*Fruit and vegetable consumption adjusted for physical activity intervention group and energy expenditure adjusted for nutrition intervention 
group.
†P values from multivariate linear regression.
‡P values from Wilcoxon sign- rank test with Bonferroni correction.
§P values from Wilcoxon sign- rank tests.
Exploratory analysis
Change in adherence from the beginning to the end of 
the trial period was examined. In the plant- based group, 
there was an increase in adherence at 6 months compared 
with the start of the intervention, both for the fruit and 
vegetable consumption, which increased from 20.0% 
(95% CI 8.9% to 39.1%, n=5 of 25), and the reduced 
dairy consumption, which increased from 60.0% (95% CI 
40.7% to 76.6%, n=15). Adherence in the lycopene group 
fell slightly from 89.3% (95% CI 72.8% to 96.3%, n=25 
of 28) within the first 4 weeks and in the physical activity 
group, which fell slightly from 59.0% (95% CI 43.4% to 
72.9%, n=23 of 39) during the first 4 weeks to reported 
adherence at 6- month follow- up (table 5).
DIsCussIOn
PrEvENT recruited 37.0% of eligible men into the cohort 
and randomised 93.1% of men from the cohort into the 
RCT. This is higher than our anticipated randomisation 
rate of 80%. Forty per cent of men in the plant- based diet 
group adhered to the fruit and vegetable component 
of the intervention at 6 months, with more than 70% 
adhering to the dairy replacement component. Almost 
80% of men in the lycopene group adhered to the inter-
vention at 6 months and just under 54% of men adhered 
to the physical activity intervention at 6 months. Those in 
the plant- based diet consumed 9.9 portions of fruit and 
vegetables per day, which was more than the nutrition 
control (6.4 portions). The lycopene group consumed 
8.2 portions per day. Over 90% completed 6- month 
follow- up.
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Table 4 Effects of interventions on blood biomarkers at 6 months
Nutrition (n=75) Physical activity (n=75)
Lycopene 
intervention
(n=28)
Median (IQR)
Plant- 
based diet 
intervention
(n=25)
Median (IQR)
Nutrition 
control
(n=22)
Median 
(IQR)
P 
value*
P (pairwise comparisons)† Physical 
activity 
intervention
(n=39)
Median (IQR)
Physical 
activity control
(n=36)
Median (IQR) P value*
Lycopene 
versus 
control
Plant based 
versus control
Lycopene 
(µmol/L)
1.30
(0.96; 1.60)
1.41
(1.12; 1.79)
1.16
(0.83; 1.39)
0.11 0.64 0.07 1.27
(0.95; 1.71)
1.36
(0.97; 1.58)
0.90
Lutein (µmol/L) 0.37
(0.28; 0.46)
0.49
(0.36; 0.57)
0.36
(0.27; 0.48)
0.05 1.00 0.07 0.40
(0.29; 0.49)
0.38
(0.26; 0.55)
0.56
Zeaxanthin 
(µmol/L)
0.09
(0.07; 0.16)
0.12
(0.10; 0.16)
0.10
(0.08; 0.14)
0.26 0.92 0.22 0.12
(0.08; 0.15)
0.11
(0.08; 0.16)
0.89
Beta 
cryptoxanthin 
(µmol/L)
0.22
(0.11; 0.39)
0.30
(0.23; 0.51)
0.23
(0.12; 0.29)
0.06 1.00 0.07 0.24
(0.13; 0.50)
0.23
(0.16; 0.35)
0.44
Alpha carotene 
(µmol/L)
0.07
(0.06; 0.09)
0.08
(0.06; 0.13)
0.07
(0.05; 0.09)
0.26 1.00 0.28 0.07
(0.05; 0.10)
0.07
(0.06; 0.09)
0.52
Beta carotene 
(µmol/L)
0.59
(0.37; 0.97)
0.81
(0.54; 1.24)
0.57
(0.46; 0.79)
0.11 1.00 0.09 0.73
(0.45; 1.16)
0.64 (0.43; 0.93) 0.47
*P- values from Kruskal- Wallis tests unless stated otherwise.
†P values from Wilcoxon rank- sum tests, with Bonferroni correction unless stated otherwise.
Table 5 Exploratory data: adherence to the interventions by self- reported daily monitoring (first 4 weeks)*
Adherence to lycopene 
intervention*
Adherence to plant- based diet intervention* Adherence to physical 
activity intervention*Fruit and vegetables Dairy replacement
Physical activity (PA)
  PA control (n=36) 33.3% (n=12) 2.8% (n=1) 19.4% (n=7) –
  PA intervention (n=39) 33.3% (n=13) 10.3% (n=4) 20.5% (n=8) 59.0% (n=23)
Nutrition
  Lycopene intervention 
(n=28)
89.3% (n=25) – – 39.3% (n=11)
  Plant- based diet 
intervention (n=25)
– 20.0% (n=5) 60.0% (n=15) 20.0% (n=5)
  Nutrition control 
(n=22)
– – – 31.8% (n=7)
*Adherence was based on the first 4 weeks of daily data monitoring forms after the participants’ earliest entry. The threshold for acceptable 
adherence was 90%, which equates to adhering to the fruit and vegetable or lycopene interventions on 26 out of a possible 28 days. 
Adherence to the PA intervention equates to doing 30+ min of walking on 18 of the 28 days.
Adherence for both elements of the plant- based inter-
vention increased from the first month of the interven-
tion to the last month. This may reflect the men’s need 
to develop new shopping, eating and social behaviours to 
incorporate the increased fruit and vegetable consump-
tion as well as the reduction in dairy milk. It should 
be noted that our definition of adherence was strict, 
expecting participants to follow the intervention more 
than 90% of the time. Previous diet and physical activity 
interventions in cancer populations have reported higher 
adherence rates of around 70%. However, in these 
instances, the interventions were either less intensive or 
definitions of adherence were not as strict as the current 
study.25–27
The findings from our blood biomarker analysis further 
contribute to the conclusion of acceptable adherence, 
with higher levels of lutein and beta cryptoxanthin evident 
in the plant- based population at 6 months, compared with 
the other groups. Both carotenoids are found in fruit and 
vegetables, for example, dark leafy greens, oranges, red 
peppers and carrots, thus implying higher consumption 
of certain fruits and vegetables in the plant- based diet 
group compared with the other groups. Almost 80% of 
the plant- based group self- reported consuming non- dairy 
milk products at 6 months compared with 8% of the lyco-
pene group and none of the control group, suggestive of 
high compliance with that intervention.
Adherence to lycopene supplements was high at almost 
80% at 6 months, a slight drop from the first 4 weeks of 
the trial where almost 90% adherence was reported. This 
may have been down to the simplicity of taking a lyco-
pene supplement, where the majority of men were able to 
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easily incorporate the capsule into their daily routine.24 It 
should be noted that despite excellent adherence to the 
lycopene supplementation, no differences in lycopene 
levels were reported in the blood biomarkers between 
men in the lycopene and other groups. Assuming self- 
reported lycopene supplementation consumption was 
correct, this finding may suggest the supplement dosage 
of 10 mg per day was not high enough. This should be 
considered when designing future lycopene interven-
tions. Our high adherence rates, however, confirm the 
feasibility of this population taking a daily lycopene 
supplement, which was an outcome of the trial.
The plant- based adherence rates were lower than the 
anticipated 75%, although adherence to the reduced 
dairy milk component were higher, almost reaching this 
target; the lycopene adherence rates were higher than 
the proposed 75%. Almost 54% of participants adhered 
to the physical activity intervention at 6 months, slightly 
lower than the 59% adhering within the first 4 weeks of 
the trial.
Overall, these randomisation and adherence rates 
suggest that men were willing to take part and generally 
followed the intervention instructions well. It should be 
noted that as a feasibility trial, we were not concerned 
with the clinical relevance of these changes, but whether 
participants would make, and adhere to, the changes for 
the duration of the trial.
The finding that participants in the plant- based diet 
intervention group consumed four additional daily 
portions of fruit or vegetables than the control group is 
substantial from a public health perspective. The lycopene 
intervention group also consumed a significantly larger 
amount of fruit and vegetables than the control group, 
although less than the plant- based diet participants. This 
may have been for one of two reasons. First, the infor-
mation sheet explained that lycopene is found in red 
food products such as tomatoes and grapefruit, thus the 
lycopene group may have increased fruit and vegetable 
consumption for this reason, as well as taking the supple-
ment. Second, it may have been the case that being in an 
active nutrition group, regardless of the specific instruc-
tions, increased participants’ awareness about their nutri-
tion, which may have resulted in them consuming more 
fruit and vegetables.12
Overall consumption of fruit and vegetables of all 
participants was reported to be high. Seven or eight 
portions per day were reported at baseline, increasing to 
8–10 portions at 6 months (nutrition control was slightly 
lower at six portions). This is proportionately higher than 
the national average. In 2013/2014, 27% of those aged 
19–64 years and 35% of those aged 65 years and over met 
the 5- A- Day recommendation.28 29 The average consump-
tion for these age groups were 4 and 4.2 portions of fruit 
and vegetables per day, respectively.29 There may be a 
number of explanations for this. Due to the informa-
tion in the public domain surrounding prostate cancer, 
which includes general advice to eat a healthy balanced 
diet, many of the men may have increased their fruit and 
vegetable consumption at time of diagnosis.11 12 Alterna-
tively, as all participants had already participated in the 
cohort, which asked questions about their diet, this may 
have made them consider their diet prior to entering the 
RCT and thus increased consumption.12 Finally, there 
may have been some over- reporting of fruit and vegetable 
consumption, either due to social desirability, inconsis-
tent recall or as a result of previously reported issues with 
the FFQ.30 This may explain the disparity between the 
reported high consumption of fruit and vegetables but 
lower adherence to the plant- based intervention.
There were no differences in levels of energy expendi-
ture reported between the physical activity intervention 
group and control group. It may have been the case that 
no differences existed or that the RPAQ was not sensi-
tive enough to detect differences. Alternatively, it may 
have been that the physical activity intervention was not 
vigorous enough to warrant a difference in score between 
the physical activity intervention groups. This is some-
thing to be noted for future physical activity interven-
tions, with the possibility of increasing the intensity of 
the intervention, with the potential to influence weight 
management.
lIMItAtIOns
There are some limitations. Except for the statistician, 
all researchers and participants were unblinded. Men 
were provided with information on the specifics of all 
trial groups and therefore there may have been cross 
over in behaviour, potentially diluting results. However, 
blinding was not feasible given the nature of the interven-
tion. The population lacked heterogeneity, particularly 
with regards to ethnicity, possibly limiting the generali-
sation of results. Many of the key variables were assessed 
via PROMs, potentially causing responder bias. However, 
we also report objective biochemical measures that 
supported the inference of good adherence, particularly 
within the plant- based group. It should be noted that the 
two key reasons for not enrolling were having too far to 
travel to attend research clinics or no response to the invi-
tation being received. If these two barriers were removed, 
then our data suggest that the cohort recruitment could 
potentially have increased to 51%.
COnClusIOn
The PrEvENT interventions were feasible as evidenced 
by high randomisation rates, high retention rates and 
excellent tolerability. Men demonstrated relatively good 
adherence to all interventions, particularly the lycopene 
supplement, brisk walking and the reduced dairy milk 
element of the plant- based diet interventions. Positive 
effects on fruit and vegetable consumption were seen in 
the plant- based diet and lycopene groups. The develop-
ment of a definitive RCT should consider: travel distance 
to research clinics; increasing the intensity of the phys-
ical activity intervention and dosage of the lycopene 
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supplementation; and possibly reducing the minimum 
criteria for adherence.
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